Momentis Surgical wins FDA clearance for its surgical robot

Momentis Surgical (formerly Memic) announced today that it received FDA 510(k) clearance for its Anovo robotic surgical platform.

Anovo received clearance for use in single-site, abdominal access across ventral hernia repair. The clearance complements Anovo’s existing approvals for natural orifice laparoscopic-assisted transvaginal benign gynecology procedures.

Momentis designed Anovo as a single-port robotics platform and clearance makes it the first such system cleared for this indication. The company says procedures performed through a single port with multiple flexible instruments could potentially result in less invasive and less traumatic outcomes for the tissue at point of entry.

Sign up for Blog Updates